About Us no banner bigger

About Us

KD Consulting Pharmaceutical Solutions (KDC) is a specialised pharmaceutical consulting practice dedicated to advancing regulatory excellence across Africa.

Established in 2007 by pharmacists Dineshree Naiker and Kacy Rajappen, the company was built on their strong industry reputations and senior leadership experience within multinational pharmaceutical organisations.

Today, KDC is recognised for delivering scientifically grounded regulatory affairs, quality assurance, pharmacovigilance, compliance and strategic advisory services with consistency, precision and integrity.

OUR VALUES

Scientific
Integrity

Quality &
Consistency

Meaningful
Contribution

Professional
Excellence

OUR TEAM

Driving Regulatory Success

KDC’s growing team includes specialists in Regulatory Affairs, Quality Assurance, Pharmacovigilance and Scientific Review, supported by administrative, finance and IT professionals. Our team’s collective experience and shared values are the foundation of our long-term client partnerships.

Kacy Rajappen

Managing Partner

Bachelor of Pharmacy (B.Pharm)

Dineshree Naiker

partner

Bachelor of Pharmacy (B.Pharm)

Dr Henk Swart

GQ & Regulatory Executive

Bachelor of Pharmacy (B.Pharm)
Master of Science (M.Sc.)
Doctor of Philosophy (Ph.D)

Nelesh Patel

QA Manager

Bachelor of Pharmacy (B.Pharm)

Mariette Botha

RA Manager

Bachelor of Pharmacy (B.Pharm)

Galieka Adams

QA & RA Administrator

B.Sc Medical Bioscience

Since 2007, KDC has supported pharmaceutical and healthcare companies by developing high-quality regulatory dossiers, conducting due-diligence assessments, and managing submissions to SAHPRA and National Regulatory Authorities across Southern Africa.

New chemical entities
Biological medicines
Generic medicines
Combination medical devices
Medical devices
Veterinary products
Complementary medicines
Stock remedies
Nutritional feed supplements

Notable Milestones

• One of the first two CTD submissions ever accepted by SAHPRA (2009)
• Multiple successful eCTD and electronic submissions
• A new medicine licensed by SAHPRA in 14 months (2020), despite COVID delays
• Proven impact supporting R&D organisations, innovative medicine developers and civil society initiatives
• First submission approved by SAHPRA filed via the Swissmedic MAGHP procedure
• Successful outcome achieved during SAHPRA’s Medical Device Registration Feasibility Study

Working in Southern Africa

Our regional expertise enables efficient market access strategies and faster go-to-market pathways.

We are highly experienced with:
• WHO Prequalification
• Swissmedic Marketing Authorisation for Global Health Products (MAGHP)
• African Medicines Regulatory Harmonisation (AMRH)
• ZaZiBoNa review processes

Industry Engagement

We remain at the forefront of evolving legislation and regulatory developments, enabling us to advise clients strategically and proactively. KDC is an active, contributing member of industry associations including HPA and SAAPI, as well as MCA and SAMED via our SAHPRA licenced sister company, Umsebe Healthcare.

Ready to Start?

Accelerate Your Regulatory Pathway

Scroll to Top
Review Your Cart
0
Add Coupon Code
Subtotal